Cambridge Investment Research Advisors’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55K | Buy |
23,690
+200
| +0.9% | +$464 | ﹤0.01% | 3535 |
|
|
2025
Q1 | $33K | Hold |
23,490
| – | – | ﹤0.01% | 3431 |
|
|
2024
Q4 | $41K | Sell |
23,490
-15
| -0.1% | -$26 | ﹤0.01% | 3390 |
|
|
2024
Q3 | $47K | Buy |
23,505
+7,000
| +42% | +$14K | ﹤0.01% | 3336 |
|
|
2024
Q2 | $37K | Sell |
16,505
-785
| -5% | -$1.76K | ﹤0.01% | 3241 |
|
|
2024
Q1 | $50K | Buy |
+17,290
| New | +$50K | ﹤0.01% | 3215 |
|